SAFETRACE V 4.0.3 STV4.0.3

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-07-13 for SAFETRACE V 4.0.3 STV4.0.3 manufactured by Haemonetics Corporation Software Solutions.

Event Text Entries

[80264101] Haemonetics discovered internally that there was a defect in the zika special labeling modification code which can allow for zika- or cmv- untested units comprising a pool to be labeled as zika negative or zika and cmv-negative on the pooled component. Although this was discovered internally, there are eight users currently utilizing this software customization and five in the software validation phase. This defect affects only those safetrace sites who have installed the zika special labeling modification and who perform testing subsequent to the pooling modification process. A new product technical bulletin will be produced to notify customers that have the customization of this issue. The defect will be fixed as a custom modification.
Patient Sequence No: 1, Text Type: N, H10


[80264102] The haemonetics software development team discovered an issue on (b)(6) 2017 with a software customization for safetrace that allows customers to have zika special testing labeling. The issue identified that a pooled component may get the zika and/or cmv negative special label when not all components in the pool were tested. If zika test results are committed after the pool occurred for one of the units comprising the pooled component, the pooled component may erroneously get the zika negative special label when not all of the components comprising the pool have been zika tested; similarly a pooled component may get the cmv neg component special label even though not all the units comprising the pool have negative cmv test results. There are currently eight customers that are live with this customization. There are no known products that were released with this label issue.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2951268-2017-00002
MDR Report Key6710833
Date Received2017-07-13
Date of Report2017-06-15
Date of Event2017-06-15
Date Mfgr Received2017-06-15
Device Manufacturer Date2016-12-01
Date Added to Maude2017-07-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS JULIE SMITH, RN
Manufacturer Street400 WOOD RD
Manufacturer CityBRAINTREE MA 02184
Manufacturer CountryUS
Manufacturer Postal02184
Manufacturer Phone7819170643
Manufacturer G1HAEMONETICS CORP
Manufacturer Street400 WOOD RD
Manufacturer CityBRAINTREE MA 02184
Manufacturer CountryUS
Manufacturer Postal Code02184
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameSAFETRACE V 4.0.3
Generic NameSAFETRCE
Product CodeMMH
Date Received2017-07-13
Model NumberSTV4.0.3
OperatorPHLEBOTOMIST
Device Availability*
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerHAEMONETICS CORPORATION SOFTWARE SOLUTIONS
Manufacturer Address4925 ROBERT J. MATTHEWS PARKWA SUITE 100 EL DORADO HILLS CA 95762 US 95762


Patients

Patient NumberTreatmentOutcomeDate
10 2017-07-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.